Afamelanotide: Phase I start

In April, Clinuvel will begin a 60-day, U.S., bridging Phase I trial in 28 healthy volunteers. Afamelanotide has Orphan Drug designation for EPP and congenital erythropoietic porphyria (Gunther's dise...